Promentis Pharmaceuticals Inc. said Friday it has received a $299,000 award from the Michael J. Fox Foundation to conduct further research into compounds that show promise for treating Parkinson’s disease. Read full Journal Sentinel story here.
Promentis Pharmaceuticals receives funding from Michael J. Fox Foundation
by Tech Council | Aug 27, 2012 | Featured, NEWSROOM, Tech Council News